Pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Monday a dividend of USD1.73 per share on outstanding common stock for the first quarter of 2026.
This is an increase from the USD1.50 per share paid in each quarter of the prior year.
The new dividend will be paid on 10 March 2026 to shareholders of record at 13 February 2026.
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline